يعرض 1 - 4 نتائج من 4 نتيجة بحث عن '"(1"', وقت الاستعلام: 1.29s تنقيح النتائج
  1. 1

    المساهمون: Institut du Cancer de Montpellier (ICM), CIC Bordeaux, Université Bordeaux Segalen - Bordeaux 2-Institut National de la Santé et de la Recherche Médicale (INSERM), Institut Desbrest de santé publique (IDESP), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM), The presented research was supported by a grant of the French National Cancer Institute (INCA-Grant n°SHS-ESP 2015–164)., Malbec, Odile

    المصدر: BMC Cancer
    BMC Cancer, BioMed Central, 2021, 21 (1), pp.60. ⟨10.1186/s12885-021-07782-z⟩
    BMC Cancer, Vol 21, Iss 1, Pp 1-10 (2021)

    وصف الملف: application/pdf

  2. 2

    المساهمون: Centre de recherche en épidémiologie et santé des populations (CESP), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Université Paris-Sud - Paris 11 (UP11)-Hôpital Paul Brousse-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Versailles Saint-Quentin-en-Yvelines (UVSQ), Université Bordeaux Segalen - Bordeaux 2, MRC Biostatistics Unit, Institute of Public Health, Université Paris-Sud - Paris 11 (UP11), Liquet, Benoit

    المصدر: Endocrine-Related Cancer
    Endocrine-Related Cancer, BioScientifica, 2014, pp.10
    HAL

  3. 3

    المساهمون: Laboratory of Genetic Medicine & Immunology, Weill Cornell Medicine [Qatar], Laboratory of Molecular Immuno-oncology, Faculté de Médecine de Monastir [Tunisie], Laboratoire de Génomique Biomédicale et Oncogénétique - Biomedical Genomics and Oncogenetics Laboratory (LR11IPT05), Université de Tunis El Manar (UTM)-Institut Pasteur de Tunis, Réseau International des Instituts Pasteur (RIIP)-Réseau International des Instituts Pasteur (RIIP), This publication was made possible by a grant from the Qatar National Research Fund (NPRP08-083-3-031). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the Qatar National Research Fund. This work was also supported by the Ministry of Higher Education and Scientific Research and the Ministry of Public Health of the Republic of Tunisia.

    المصدر: Breast Cancer Research and Treatment
    Breast Cancer Research and Treatment, Springer Verlag, 2012, 135 (3), pp.715-24. ⟨10.1007/s10549-012-2202-6⟩

    مصطلحات موضوعية: Cancer Research, Survival, [SDV]Life Sciences [q-bio], Genome-wide association study, 0302 clinical medicine, Preclinical Study, Breast cancer, MESH: Aged, 80 and over, Genotype, GWAS, MESH: Heterozygote, Genetics, Aged, 80 and over, MESH: Aged, 0303 health sciences, MESH: Middle Aged, MESH: Polymorphism, Single Nucleotide, High Mobility Group Proteins, MESH: Genetic Predisposition to Disease, Middle Aged, Prognosis, MESH: Case-Control Studies, 3. Good health, Arabs, Receptors, Estrogen, Oncology, 030220 oncology & carcinogenesis, Chromosomes, Human, Pair 2, MESH: Receptors, Estrogen, Female, Tunisians, Receptors, Progesterone, MESH: Tunisia, Chromosomes, Human, Pair 8, Adult, MESH: Receptors, Progesterone, Heterozygote, Tunisia, MESH: Receptor, Fibroblast Growth Factor, Type 2, MESH: Chromosomes, Human, Pair 2, MAP Kinase Kinase Kinase 1, Single-nucleotide polymorphism, Breast Neoplasms, [SDV.CAN]Life Sciences [q-bio]/Cancer, Biology, Polymorphism, Single Nucleotide, 03 medical and health sciences, Genetic variation, medicine, Humans, Genetic Predisposition to Disease, Allele, Receptor, Fibroblast Growth Factor, Type 2, 030304 developmental biology, Genetic association, Aged, MESH: MAP Kinase Kinase Kinase 1, MESH: Humans, MESH: Adult, medicine.disease, Minor allele frequency, Case-Control Studies, MESH: Genome-Wide Association Study, Trans-Activators, MESH: Arabs, Apoptosis Regulatory Proteins, MESH: Chromosomes, Human, Pair 8, MESH: Female, MESH: Breast Neoplasms, Genome-Wide Association Study

  4. 4

    المساهمون: Biologie des Interactions Neurones / Glie, Université Pierre et Marie Curie - Paris 6 (UPMC)-Institut National de la Santé et de la Recherche Médicale (INSERM), Laboratoire de Chimie et de Biochimie Pharmacologiques et Toxicologiques (LCBPT - UMR 8601), Institut de Chimie du CNRS (INC)-Centre National de la Recherche Scientifique (CNRS)-Université Paris Cité (UPCité), Institut de Chimie du CNRS (INC)-Centre National de la Recherche Scientifique (CNRS)-Université de Paris (UP), Service de Neurologie [CHU Pitié-Salpêtrière], IFR70-CHU Pitié-Salpêtrière [AP-HP], Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), UPMC - Département de neurologie 2 - Mazarin, Université Pierre et Marie Curie - Paris 6 (UPMC)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-CHU Pitié-Salpêtrière [AP-HP], Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Immunologie cellulaire et tissulaire, Université Pierre et Marie Curie - Paris 6 (UPMC)-IFR113-Institut National de la Santé et de la Recherche Médicale (INSERM), CHU Pitié-Salpêtrière [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Service de neurologie 1 [CHU Pitié-Salpétrière], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-CHU Pitié-Salpêtrière [AP-HP], Idbaih, Ahmed, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Sorbonne Université (SU)

    المصدر: Cancer Genetics and Cytogenetics
    Cancer Genetics and Cytogenetics, 2007, 177 (2), pp.103-107. ⟨10.1016/J.CANCERGENCYTO.2007.06.010⟩
    Cancer Genetics and Cytogenetics, Elsevier, 2007, 177 (2), pp.103-107. ⟨10.1016/J.CANCERGENCYTO.2007.06.010⟩
    Cancer Genetics and Cytogenetics, Elsevier, 2007, 177 (2), pp.103-7. ⟨10.1016/j.cancergencyto.2007.06.010⟩
    Cancer Genetics and Cytogenetics, 2007, 177 (2), pp.103-7. ⟨10.1016/j.cancergencyto.2007.06.010⟩